Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 1 AL 15

Attention Measures of Accuracy, Variability, and Fatigue Detect Early Response to Donepezil in Alzheimer's Disease: A Randomized, Double-blind, Placebo-Controlled Pilot Trial

Vila-Castelar C, Ly JJ, Kaplan L, Van Dyk K, Berger JT, Macina LO, Stewart JL, Foldi NS.

Arch Clin Neuropsychol. 2019 May 1;34(3):277-289. doi: 10.1093/arclin/acy032.

99mTc-labeled Small Molecules for Diagnosis of Alzheimer's Disease: Past, Recent and Future Perspectives

Molavipordanjani S, Emami S, Hosseinimehr SJ.

Curr Med Chem. 2019;26(12):2166-2189. doi: 10.2174/0929867325666180410104023.

Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease

Yang J, Yang J, Li Y, Xu Y, Ran C.

Mol Imaging Biol. 2019 Feb;21(1):35-43. doi: 10.1007/s11307-018-1213-z.

[Collation of word retrieval disorders in patients with Alzheimer's dementia]

Camerer-Waldecker C, Supprian T.

Nervenarzt. 2019 Apr;90(4):399-407. doi: 10.1007/s00115-018-0572-7.

Effects of Acupuncture on Alzheimer's Disease: Evidence from Neuroimaging Studies

Yu CC, Ma CY, Wang H, Kong LH, Zhao Y, Shen F, Wu M.

Chin J Integr Med. 2019 Aug;25(8):631-640. doi: 10.1007/s11655-018-2993-3.

Use of Physical Activity Questionnaires in People With Dementia: A Scoping Review

Farina N, Hughes LJ, Watts A, Lowry RG.

J Aging Phys Act. 2019 Jun 1;27(3):413-421. doi: 10.1123/japa.2018-0031. Epub 2019 Mar 13.

Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology

Smith R, Wibom M, Pawlik D, Englund E, Hansson O.

JAMA Neurol. 2019 Mar 1;76(3):310-317. doi: 10.1001/jamaneurol.2018.3692.

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Farlow MR, Thompson RE, Wei LJ, Tuchman AJ, Grenier E, Crockford D, Wilke S, Benison J, Alkon DL.

J Alzheimers Dis. 2019;67(2):555-570. doi: 10.3233/JAD-180759.

Network localization of heterogeneous neuroimaging findings

Darby RR, Joutsa J, Fox MD.

Brain. 2019 Jan 1;142(1):70-79. doi: 10.1093/brain/awy292.

Dementia-friendly community initiatives: An integrative review

Shannon K, Bail K, Neville S.

J Clin Nurs. 2019 Jun;28(11-12):2035-2045. doi: 10.1111/jocn.14746. Epub 2019 Jan 29.

Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report

Supasitthumrong T, Bolea-Alamanac BM, Asmer S, Woo VL, Abdool PS, Davies SJC.

Br J Clin Pharmacol. 2019 Apr;85(4):690-703. doi: 10.1111/bcp.13844. Epub 2019 Feb 8.

Default Mode Network Connectivity in Alzheimers Disease

Yıldırım E, Soncu Büyükişcan E.

Turk Psikiyatri Derg. 2019 Winter;30(4):279-286.

Quantifying placebo responses in clinical evaluation of neuropsychiatric symptoms in Alzheimer's disease

Zhang N, Lv Y, Li H, Chen J, Li Y, Yin F, Li L, Zheng Q.

Eur J Clin Pharmacol. 2019 Apr;75(4):497-509. doi: 10.1007/s00228-018-02620-x. Epub 2019 Jan 5.

Bad news and good news in AD, and how to reconcile them

Knopman DS.

Nat Rev Neurol. 2019 Feb;15(2):61-62. doi: 10.1038/s41582-018-0131-7.

Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies

Mueller C, Soysal P, Rongve A, Isik AT, Thompson T, Maggi S, Smith L, Basso C, Stewart R, Ballard C, O'Brien JT, Aarsland D, Stubbs B, Veronese N.

Ageing Res Rev. 2019 Mar;50:72-80. doi: 10.1016/j.arr.2019.01.005. Epub 2019 Jan 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias